Distribution of mast cell subtypes in interstitial cystitis: implications for novel diagnostic and therapeutic strategies?
- 15 May 2018
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 71 (9) , 840-844
Abstract
Aims: To identify the presence and geographical distribution of mast cell (MC) subtypes: MCT (tryptase positive–chymase negative) and MCTC (tryptase positive–chymase positive) in bladder tissue. Methods: Bladder tissue was obtained from patients with painful bladder syndrome/interstitial cystitis (n=14) and normal histology from University Hospital Southampton tissue bank. Sequential tissue slices were immunohistochemically stained for MC subtypes using anti-MC tryptase (for MCT and MCTC) and anti-MC chymase (for MCTC). Stained sections were photographed, and positively stained MCs were quantified using ImageJ. Data were analysed using descriptive statistics and individual paired t-tests. Results: There was a significant difference in the density of MCs between each layer of the disease bladder, with the greatest accumulation within the detrusor (pTC subtype in the lamina (p=0.009) in painful bladder syndrome/interstitial cystitis. Conclusions: Our results suggest that mastocytosis is present within all layers of disease bladder, especially the muscle layer. The varying increase in MC subtypes in the lamina and mucosa may explain the variability in painful bladder syndrome/interstitial cystitis symptoms. A high influx of MCTC in the mucosa of individuals who also had ulceration noted within their diagnostic notes may be of the Hunner’s ulcer subclassification. These findings suggest a relationship between the pathogenesis of MC subtypes and the clinical presentation of painful bladder syndrome/interstitial cystitis. A cohort study would further elucidate the diagnostic and/or therapeutic potential of MCs in patients with painful bladder syndrome/interstitial cystitis.Keywords
This publication has 19 references indexed in Scilit:
- Glycosaminoglycan Therapy for Bladder Diseases: Emerging New TreatmentsEuropean Urology Supplements, 2011
- The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic painBJU International, 2010
- Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cellsJournal of Neuroimmunology, 2010
- Mast cells and mastocytosisBlood, 2008
- The Mast Cell in Interstitial Cystitis: Role in Pathophysiology and PathogenesisUrology, 2007
- Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1β and tumor necrosis factor-αUrology, 2006
- MAST CELLS MEDIATE THE SEVERITY OF EXPERIMENTAL CYSTITIS IN MICEJournal of Urology, 1999
- Increased number of substance P positive nerve fibres in interstitial cystitisBritish Journal of Urology, 1995
- Nerve fibre proliferation in interstitial cystitisVirchows Archiv, 1990
- Contrast enhancement of the brownish horseradish peroxidase-activated 3,3'-diaminobenzidine tetrahydrochloride reaction product in black and white photomicrography by the use of interference filters.Journal of Histochemistry & Cytochemistry, 1984